About Piramal Pharma Ltd.
Piramal Pharma Ltd is a prominent pharmaceutical company in India, part of the larger Piramal Group. The company provides a range of pharmaceutical solutions, including Contract Development (Job Work) and Manufacturing Organization (CDMO) services, complex hospital generics, and consumer healthcare products. Piramal Pharma CDMO arm offers end to end drug development and manufacturing services for global pharmaceutical and biotech companies, handling the entire lifecycle from early-stage research to commercial production.
So Here We Are Taking Analysis Of Piramal Pharma Share Price Target For Long Term With Support of Technical And Fundamental And Price Action And Past Performance.
Profile Overview of Piramal Pharma Ltd
| Details Of Stock / Company | Information |
| Stock Name | Piramal Pharma Ltd |
| Stock Symbol | PPLPHARMA |
| Stock Exchange | NSE And BSE |
| Market Cap ( Rs in Cr ) | Cr 36568 |
| Face Value | Rs 10 |
| P/E Ratio | 625 |
| Dividend Yield | 0.04% |
| Debt To Equity Ratio | 0.61 |
| Headquarter | MUMBAI |
| Established In | 2020 |
| Managing Directors | —– |
Shareholding Pattern of Piramal Pharma Ltd
| Shareholding Pattern | Amount In % |
| Promoters | 34.95% |
| Retails & Others | 19.51% |
| DII Domestics Institution | 2.59% |
| FII Foreign Institution | 31.73% |
| Mutual Fund | 11.21% |
Piramal Pharma Share Price Target 2024
Here First We See Fundamental Analysis As Per The NSE Data So Piramal Pharma Having Market Cap of Rs 36568 Cr So It Is Small Cap Company And PE Ratio Are 625 Time That Is Higher Then The Industry Standers And Face Value of 10 Rs And Book Value Is Around 56.22 Rs That All The Data Indicating Positive Fundamental Data.
| Month | Target Price |
| January | Rs 134 To 150 |
| February | Rs 144 To 130 |
| March | Rs 135 To 144 |
| April | Rs 129 To 146 |
| May | Rs 166 To 143 |
| June | Rs 135 To 162 |
| July | Rs 144 To 177 |
| August | Rs 166 To 193 |
| September | Rs 187 To 243 |
| October | Rs 209 To 274 |
| November | Rs 271 To 290 |
| December | Rs 280 To 310 |
Piramal Pharma Share Price Target 2025
Here As Per The Shareholding Pattern of Piramal Pharma FII And DII Data Then FII Hold 31.73% And DII Hold 2.59% That Is Good And It Is Also Indicating Strong Fundamental And Promoters Having 34.95% And It Is Increasing It Is Also Good for The Fundamental Data And Retails & Others 19.51% And Mutual Fund Having 11.21% it Is Also Good Signal For The Long Term.
| Month | Target Price |
| January | Rs 265 To 287 |
| February | Rs 281 To 299 |
| March | Rs 295 To 315 |
| April | Rs 299 To 325 |
| May | Rs 305 To 318 |
| June | Rs 309 To 331 |
| July | Rs 315 To 349 |
| August | Rs 328 To 363 |
| September | Rs 339 To 359 |
| October | Rs 343 To 368 |
| November | Rs 351 To 390 |
| December | Rs 387 To 420 |
Read Also :- GTL Infra Share Price Target :2024, 2025, 2026, 2027, 2028, 2029, 2030, 2040, 2045, 2050
Read Also :- Reddit Stock Price Prediction : 2024, 2025, 2026, 2027, 2028, 2029, 2030, 2035, 2040, 2045, 2050
Piramal Pharma Share Price Target 2026
As Per The Current Time Price Action And Chart Patterns Based on It We Are doing Technical Analysis Of Piramal Pharma Share Price Target For The Long As Per The Monthly Time Frame Candle Sticks Patterns Are Indicating That Trend Are Bullish And It Will Given More Upside Trend In Coming Year And It May Providing More Returens.
| Month | Target Price |
| January | Rs 405 To 425 |
| February | Rs 415 To 437 |
| March | Rs 420 To 441 |
| April | Rs 428 To 449 |
| May | Rs 439 To 451 |
| June | Rs 440 To 468 |
| July | Rs 449 To 479 |
| August | Rs 451 To 489 |
| September | Rs 459 To 491 |
| October | Rs 451 To 489 |
| November | Rs 470 To 499 |
| December | Rs 481 To 518 |
Piramal Pharma Share Price Target 2027
For Understanding Market Trend And Stock Analysis And Candlesticks Patterns Here We Are Attaching Current Chart Patterns.
| Month | Target Price |
| January | Rs 481 To 521 |
| February | Rs 511 To 528 |
| March | Rs 528 To 548 |
| April | Rs 531 To 568 |
| May | Rs 539 To 588 |
| June | Rs 559 To 598 |
| July | Rs 561 To 610 |
| August | Rs 569 To 621 |
| September | Rs 570 To 631 |
| October | Rs 585 To 649 |
| November | Rs 590 To 661 |
| December | Rs 598 To 679 |
Piramal Pharma Share Price Target 2028
Here We Are Taking Technical Analysis Using Fibonacci Retrenchment As Per The Fib Retrenchment The Price May Take Pull Back Upto Rs 163 to 183 And It May Continues The Trend On The Bullish Side And It May Provide More New High Returns.
| Month | Target Price |
| January | Rs 680 To 631 |
| February | Rs 649 To 669 |
| March | Rs 651 To 687 |
| April | Rs 649 To 698 |
| May | Rs 658 To 710 |
| June | Rs 681 To 749 |
| July | Rs 689 To 738 |
| August | Rs 679 To 727 |
| September | Rs 710 To 749 |
| October | Rs 728 To 768 |
| November | Rs 739 To 781 |
| December | Rs 748 To 795 |
Piramal Pharma Share Price Target 2029
As Per Past Data And Price Action Analysis Here We Are Taken Deep Understanding For Predict Piramal Pharma Share Price Target For Long Term So Here We Are Using Relative strength Index (RSI) And ADX So As Per The Both Indicators Forecasting Positive View RSI Showing Oversold That Is Positive Signal ADX Are Also Suggest More Signal On The Chart.
| Month | Target Price |
| January | Rs 758 To 710 |
| February | Rs 649 To 699 |
| March | Rs 668 To 730 |
| April | Rs 681 To 748 |
| May | Rs 698 To 769 |
| June | Rs 710 To 787 |
| July | Rs 730 To 781 |
| August | Rs 745 To 798 |
| September | Rs 757 To 821 |
| October | Rs 769 To 791 |
| November | Rs 781 To 799 |
| December | Rs 793 To 838 |
Piramal Pharma Share Price Target 2030
Here As Per The EMA (Moving Average Exponential) of 100 And 200 Periods Price Are Traded On The EMA And Its Indicate Bullish Trend On The Chart And Both the EMA Are Trendy On The Upperside With 30% Angle That Shows Good Signal On Then Chart And It May Shows More Buyer Strength On The chart So As Per The Forecasting Piramal Pharma Share Price Target May Show More Positive Strength In Future.
| Month | Target Price |
| January | Rs 793 To 838 |
| February | Rs 810 To 845 |
| March | Rs 820 To 869 |
| April | Rs 835 To 891 |
| May | Rs 868 To 878 |
| June | Rs 858 To 899 |
| July | Rs 865 To 890 |
| August | Rs 879 To 899 |
| September | Rs 898 To 921 |
| October | Rs 915 To 938 |
| November | Rs 928 To 969 |
| December | Rs 949 To 987 |
Piramal Pharma Share Price Target 2031, 2035, 2040, 2045, 2050
| Year | Quarterly Price Target |
| 2031 | Rs 850 To 990 |
| 2032 | Rs 910 To 1080 |
| 2033 | Rs 950 To 1130 |
| 2034 | Rs 1060 To 1190 |
| 2035 | Rs 1120 To 1230 |
| 2036 | Rs 1150 To 1280 |
| 2037 | Rs 1200 To 1300 |
| 2038 | Rs 1250 To 1380 |
| 2039 | Rs 1300 To 1400 |
| 2040 | Rs 1280 To 1390 |
| 2045 | Rs 1300 To 1800 |
| 2050 | Rs 1500 To 1900 |
Conclusion !
Overall Stock Strength Are Indicating Positive On The Technically And Fundamentally As Per The Data And As Per The Technical Forecasting Piramal Pharma Share Price Target May Become More Positive In Coming Year Also Stock Are Looking Good At Fundamental Level And It May Indicate More Positive Strength On The Analysis.
FAQs:-
Is Piramal Pharma a good stock to buy?
As Per The Current Analysis And Price Action Stock Are Looking good At Technical Level And Fundamental Level It May Having Buyer Strength On The Chart So Piramal Pharma a good stock to buy For long Term.
What is the target price of Piramal Pharma in 2025?
As Per The Current Technical Analysis Piramal Pharma Showing Buyer Strength On The Chart And target price of Piramal Pharma in 2025 Is May Around Rs 265 To 420.
What is the target for Piramal Pharma in 2030?
As Per The Current Analysis Of Piramal Pharma Price Are Indicating Strong Buying Strength On The Chart And target for Piramal Pharma in 2030 It May Around Rs 800 To 980 Rs.
Disclaimer
This Article Is Information Purpose Only, Please Do Not Consider As A Professional Advice For Investment. This Share Price Target Or Prediction Is Based On Our Technical And Fundamental Analysis, It May Change In Future Due To Market Sentiments, We Are Not SEBI Registered Advisers, If You Want Investment Then Please Contact Registered Financial Adviser.
